The STAR Prospective Clinical Series
| Status: | Active, not recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - 100 |
| Updated: | 4/21/2016 |
| Start Date: | June 2013 |
| End Date: | March 2016 |
The DFINE STAR™ Tumor Ablation Prospective Clinical Series
Prospective clinical series to gather post tumor ablation clinical outcomes from subjects
with painful spinal metastases following targeted radiofrequency ablation (t-RFA) treatment
with the STAR™ Tumor Ablation System.
with painful spinal metastases following targeted radiofrequency ablation (t-RFA) treatment
with the STAR™ Tumor Ablation System.
Inclusion Criteria:
- The STAR™ Tumor Ablation System is indicated for palliative treatment in spinal
procedures by ablation of metastatic malignant lesions in a vertebral body.
Exclusion Criteria:
- The device is contraindicated in subjects with heart pacemakers, or other electronic
device implants.
- The device is contraindicated in vertebral body levels C1-7.
We found this trial at
8
sites
University of Southern California The University of Southern California is one of the world’s leading...
Click here to add this to my saved trials
Suburban Hospital Suburban Hospital is a community-based, not-for-profit hospital serving Montgomery County and the surrounding...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
University of Kansas Medical Center The University of Kansas Medical Center serves Kansas through excellence...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials